Latigo Biotherapeutics, Inc. share price logo

Latigo Biotherapeutics, Inc.

NASDAQ: LTGO

Small Cap

$22.55

-1.38

(-5.77%)

as on

Latigo Biotherapeutics, Inc. Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $22.21
    $24.80
    downward going graph

    1.51%

    Downside

    9.98%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Latigo Biotherapeutics, Inc. share price movements today

Previous Close
$23.93
Open
$24.08
Volume
470.5K
Market Cap
$1.5B
Day's Low - High
$22.21 - $24.80

Latigo Biotherapeutics, Inc. Historical Returns

1 Month Return
+ 14.28 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Latigo Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Check Latigo Biotherapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-2.18

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Latigo Biotherapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Latigo Biotherapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$1.5BNANA0.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Analyst Recommendation on Latigo Biotherapeutics, Inc. Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Latigo Biotherapeutics, Inc.. Average target price of $57.6666666666667

Indian Investors' Interest in Latigo Biotherapeutics, Inc. Stock

Search interest for Latigo Biotherapeutics, Inc. Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:34% versus previous 30 day period

Latigo Biotherapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2025
Jun 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-
-
-
-
EBITDA
-
-
-
-
Interest Expense
-
-
-
-
Depreciation
-
-
-
-
Income Before Tax
-
-
-
-
Income Tax Expense
-
-
-
-
Net Income
-20
-25
-22
-25
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Latigo Biotherapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-
-
EBITDA
-
-
Interest Expense
-
-
Depreciation
-
-
Income Before Tax
-
-
Income Tax Expense
-
-
Net Income
-61
-109
Net Profit Margin
0.00%
0.00%

Global Institutional Holdings in Latigo Biotherapeutics, Inc.

Funds
Holdings
Vanguard
0.13%

Insights on Latigo Biotherapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LTGO stock has moved up by 1.8%

About Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
OrganisationLatigo Biotherapeutics, Inc.
Headquarters1300 Rancho Conejo Boulevard, Suite 305, Thousand Oak, CA, 91320, US
IndustryMedical - Pharmaceuticals
CEONima Farzan
E-voting on sharesClick here to vote

Key Management of Latigo Biotherapeutics, Inc.

Name

Title

Ms. Polina German Pharm.D.

Senior Vice President of Clinical Pharmacology & Translational

Ms. Sabrina Nieder

VP & Corporate Controller

Vicki Holloway

Secretary

Ms. Julia Chapman

Senior Vice President of Operations

Ms. Caroline Dougherty

Vice President of Corporate Development

Mr. Bryan Moyer Ph.D.

Senior Vice President of Discovery

Mr. Nima Farzan M.B.A.

CEO, President & Director

Ms. Neha Krishnamohan

Chief Business Officer & CFO

Dr. Neil Kumar Singla M.D.

Chief Medical Officer

FAQs

What is Latigo Biotherapeutics, Inc. share price today?

Latigo Biotherapeutics, Inc. share price today is $22.55 as on at the close of the market. Latigo Biotherapeutics, Inc. share today touched a day high of $24.80 and a low of $22.21.

What is the 52 week high and 52 week low for Latigo Biotherapeutics, Inc. share?

Latigo Biotherapeutics, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Latigo Biotherapeutics, Inc. stock price today i.e. is closed at $22.55,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Latigo Biotherapeutics, Inc.'s market capitalisation today?

Latigo Biotherapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Latigo Biotherapeutics, Inc. Stock (LTGO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Latigo Biotherapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Latigo Biotherapeutics, Inc. Shares that will get you 0.0665 shares as per Latigo Biotherapeutics, Inc. share price of $22.55 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Latigo Biotherapeutics, Inc. Stock (LTGO) from India?

Indian investors can start investing in Latigo Biotherapeutics, Inc. (LTGO) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Latigo Biotherapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Latigo Biotherapeutics, Inc. share’s latest price of $22.55 as on September 19, 2026 at 8:45 am IST, you will get 0.4435 shares of Latigo Biotherapeutics, Inc.. Learn more about fractional shares .